Ergocalciferol Supplementation in Children with CKD Delays the Onset of Secondary Hyperparathyroidism | Zendy

Rukshana Shroff | Zendy; Mandy Wan | Zendy; Ambrose Gullett | Zendy; Sarah Ledermann | Zendy; Rachel Shute | Zendy; Craig Knott | Zendy; David G. Wells | Zendy; Helen Aitkenhead | Zendy; Bahee Manickavasagar | Zendy; William van’t Hoff | Zendy; Lesley Rees | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ergocalciferol Supplementation in Children with CKD Delays the Onset of Secondary Hyperparathyroidism

Author(s) -

Rukshana Shroff,

Mandy Wan,

Ambrose Gullett,

Sarah Ledermann,

Rachel Shute,

Craig Knott,

David G. Wells,

Helen Aitkenhead,

Bahee Manickavasagar,

William van’t Hoff,

Lesley Rees

Publication year - 2012

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04760511

Subject(s) - ergocalciferol , medicine , placebo , vitamin d and neurology , vitamin d deficiency , hyperparathyroidism , secondary hyperparathyroidism , confidence interval , clinical endpoint , gastroenterology , endocrinology , randomized controlled trial , parathyroid hormone , cholecalciferol , calcium , pathology , alternative medicine

Vitamin D deficiency is an important contributor to the development of hyperparathyroidism and is independently associated with cardiovascular and bone disease. The hypothesis was that nutritional vitamin D (ergocalciferol) supplementation in children with CKD stages 2-4 delays the onset of secondary hyperparathyroidism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research